BBIO: BridgeBio Pharma, Inc. Stock

by  •  • Comments Off on BBIO: BridgeBio Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4,487.72
Enterprise Value ($M) 5,850.24
Book Value ($M) -1,342.54
Book Value / Share -7.28
Price / Book -3.34
NCAV ($M) -1,411.32
NCAV / Share -7.65
Price / NCAV -3.18

Profitability (mra)
Return on Invested Capital (ROIC) -1.60
Return on Assets (ROA) -1.03
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.42
Current Ratio 3.42

Balance Sheet (mrq) ($M)
Current Assets 477.59
Assets 546.38
Liabilities 1,888.91
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.30
Operating Income -599.44
Net Income -643.20
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -527.72
Cash from Investing 54.03
Cash from Financing 451.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-16 13G/A Kumar Neil 5.59 1.38
02-13 13G/A Vanguard Group Inc 7.36 20.85
01-29 13G/A BlackRock Inc. 5.80 3.28
01-23 13G/A State Street Corp 2.92 -42.49
11-22 13D/A Viking Global Investors Lp 15.70 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 298,848 801,831 37.27
2024-04-25 246,666 668,465 36.90
2024-04-24 225,300 538,861 41.81
2024-04-23 307,479 500,959 61.38
2024-04-22 392,726 736,800 53.30

(click for more detail)

Similar Companies
AVIR – Atea Pharmaceuticals, Inc. AVRO – AVROBIO, Inc.
AVXL – Anavex Life Sciences Corp. BCRX – BioCryst Pharmaceuticals, Inc.
BDTX – Black Diamond Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io